These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24959285)

  • 1. Safety and efficacy of image-guided enzyme-targeting radiosensitization and intraoperative radiotherapy for locally advanced unresectable pancreatic cancer.
    Nishioka A; Ogawa Y; Miyatake K; Tadokoro M; Nogami M; Hamada N; Kubota K; Kariya S; Kohsaki T; Saibara T; Okabayashi T; Hanazaki K
    Oncol Lett; 2014 Jul; 8(1):404-408. PubMed ID: 24959285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic response to a novel enzyme-targeting radiosensitization treatment (Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas) in patients with recurrent breast cancer.
    Aoyama N; Ogawa Y; Yasuoka M; Takahashi M; Iwasa H; Miyatake K; Yamanishi T; Hamada N; Tamura T; Nishioka A; Yamagami T
    Oncol Lett; 2016 Jul; 12(1):29-34. PubMed ID: 27347095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic results of a novel enzyme-targeting radiosensitization treatment, Kochi oxydol-radiation therapy for unresectable carcinomas II, in patients with stage I primary breast cancer.
    Aoyama N; Ogawa Y; Yasuoka M; Ohgi K; Iwasa H; Miyatake K; Yoshimatsu R; Yamanishi T; Hamada N; Tamura T; Kobayashi K; Murata Y; Miyamura M; Yamagami T
    Oncol Lett; 2017 Jun; 13(6):4741-4747. PubMed ID: 28599475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic response to a novel enzyme-targeting radiosensitization treatment (KORTUC II) for residual lesions in patients with stage IV primary breast cancer, following induction chemotherapy with epirubicin and cyclophosphamide or taxane.
    Aoyama N; Ogawa Y; Yasuoka M; Iwasa H; Miyatake K; Yoshimatsu R; Yamanishi T; Hamada N; Tamura T; Kobayashi K; Murata Y; Yamagami T; Miyamura M
    Oncol Lett; 2017 Jan; 13(1):69-76. PubMed ID: 28123524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I study of a new radiosensitizer containing hydrogen peroxide and sodium hyaluronate for topical tumor injection: a new enzyme-targeting radiosensitization treatment, Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II).
    Ogawa Y; Kubota K; Ue H; Kataoka Y; Tadokoro M; Miyatake K; Tsuzuki K; Yamanishi T; Itoh S; Hitomi J; Hamada N; Kariya S; Fukumoto M; Nishioka A; Inomata T
    Int J Oncol; 2009 Mar; 34(3):609-18. PubMed ID: 19212665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-surgical care for locally advanced breast cancer: radiologically assessed therapeutic outcome of a new enzyme-targeting radiosensitization treatment, Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II) with systemic chemotherapy.
    Miyatake K; Kubota K; Ogawa Y; Hamada N; Murata Y; Nishioka A
    Oncol Rep; 2010 Nov; 24(5):1161-8. PubMed ID: 20878106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New radiosensitization treatment (KORTUC I) using hydrogen peroxide solution-soaked gauze bolus for unresectable and superficially exposed neoplasms.
    Ogawa Y; Ue H; Tsuzuki K; Tadokoro M; Miyatake K; Sasaki T; Yokota N; Hamada N; Kariya S; Hitomi J; Nishioka A; Nakajima K; Ikeda M; Sano S; Inomata T
    Oncol Rep; 2008 Jun; 19(6):1389-94. PubMed ID: 18497941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial Assessment of Therapeutic Response to a New Radiosensitization Treatment, Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II), in Patients with Stage I/II Breast Cancer Using Breast Contrast-Enhanced Magnetic Resonance Imaging.
    Yaogawa S; Ogawa Y; Morita-Tokuhiro S; Tsuzuki A; Akima R; Itoh K; Morio K; Yasunami H; Onogawa M; Kariya S; Nogami M; Nishioka A; Miyamura M
    Cancers (Basel); 2015 Dec; 8(1):. PubMed ID: 26703733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a novel enzyme-targeting radiosensitizer (KORTUC) containing hydrogen peroxide for intratumoral injection for patients with low linear energy transfer-radioresistant neoplasms.
    Tokuhiro S; Ogawa Y; Tsuzuki K; Akima R; Ue H; Kariya S; Nishioka A
    Oncol Lett; 2010 Nov; 1(6):1025-1028. PubMed ID: 22870106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computed Tomography Demonstration of the Production and Distribution of Oxygen Gas Following Intratumoral Injection of a New Radiosensitizer (KORTUC) for Patients with Breast Cancer-Is Intratumoral Injection Not an Ideal Approach to Solve the Major Problem of Tumor Hypoxia in Radiotherapy?
    Hayashi N; Ogawa Y; Kubota K; Okino K; Akima R; Morita-Tokuhiro S; Tsuzuki A; Yaogawa S; Nishioka A; Miyamura M
    Cancers (Basel); 2016 Apr; 8(4):. PubMed ID: 27043633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New enzyme-targeting radiosensitizer (KORTUC II) treatment for locally advanced or recurrent breast cancer.
    Shimbo T; Nakata M; Yoshioka H; Sato C; Hori A; Kimura K; Iwamoto M; Yoshida K; Uesugi Y; Akiyama H; Nihei K
    Mol Clin Oncol; 2021 Nov; 15(5):241. PubMed ID: 34650808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-surgical therapy and radiologic assessment of stage I breast cancer treatment with novel enzyme-targeting radiosensitization: Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, type II (KORTUC II).
    Hitomi J; Kubota K; Ogawa Y; Hamada N; Murata Y; Nishioka A
    Exp Ther Med; 2010 Sep; 1(5):769-775. PubMed ID: 22993600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Novel Enzyme-Targeting Radiosensitizer (New KORTUC) Using a Gelatin-Based Hydrogel Instead of a Sodium Hyaluronate.
    Morita-Tokuhiro S; Ogawa Y; Yokota N; Tsuzuki A; Oda H; Ishida N; Aoyama N; Nishioka A
    Cancers (Basel); 2016 Jan; 8(1):. PubMed ID: 26751477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actual practice of Kochi oxydol radiation therapy for unresectable carcinomas by intra-tumoral administration of hydrogen peroxide as a radiosensitizer.
    Obata S; Ishimaru Y; Miyagi S; Nakatake M; Kuroiwa A; Ohta Y; Kan T; Kanegae S; Inoue Y; Nishizato R; Miyazaki K
    Mol Clin Oncol; 2022 Mar; 16(3):68. PubMed ID: 35154708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KORTUC, a novel hydrogen peroxide‑based radiosensitizer for the enhancement of brachytherapy in patients with unresectable recurrent uterine cervical cancer.
    Shimbo T; Yoshida K; Nakata M; Kobata K; Ogawa T; Kihara A; Sato C; Hori A; Takeno S; Yoshioka H; Akiyama H; Nihei K
    Oncol Lett; 2023 Sep; 26(3):378. PubMed ID: 37559582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Surgical Breast-Conserving Treatment (KORTUC-BCT) Using a New Radiosensitization Method (KORTUC II) for Patients with Stage I or II Breast Cancer.
    Ogawa Y; Kubota K; Aoyama N; Yamanishi T; Kariya S; Hamada N; Nogami M; Nishioka A; Onogawa M; Miyamura M
    Cancers (Basel); 2015 Nov; 7(4):2277-89. PubMed ID: 26593948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and effectiveness of a new enzyme-targeting radiosensitization treatment (KORTUC II) for intratumoral injection for low-LET radioresistant tumors.
    Ogawa Y; Kubota K; Ue H; Tadokoro M; Matsui R; Yamanishi T; Hamada N; Kariya S; Nishioka A; Nakajima H; Tarutani M; Sano S
    Int J Oncol; 2011 Sep; 39(3):553-60. PubMed ID: 21667020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External and intraoperative radiotherapy for resectable and unresectable pancreatic cancer: analysis of survival rates and complications.
    Nishimura Y; Hosotani R; Shibamoto Y; Kokubo M; Kanamori S; Sasai K; Hiraoka M; Ohshio G; Imamura M; Takahashi M; Abe M
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):39-49. PubMed ID: 9300738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose-rate interstitial brachytherapy with hypoxic radiosensitizer KORTUC II for unresectable pelvic sidewall recurrence of uterine cervical cancer: a case report.
    Nakata M; Yoshida K; Shimbo T; Yoshikawa N; Yoshioka H; Hori A; Sato C; Uesugi Y; Kogata Y; Masui K; Murakami N; Kashihara T; Akiyama H; Tselis N; Ohmichi M; Nihei K
    J Contemp Brachytherapy; 2020 Dec; 12(6):606-611. PubMed ID: 33437310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Changes in Tumor Shadows and Microcalcifications on Mammography Following KORTUC II, a New Radiosensitization Treatment without any Surgical Procedure for Elderly Patients with Stage I and II Breast Cancer.
    Tsuzuki A; Ogawa Y; Kubota K; Tokuhiro S; Akima R; Yaogawa S; Itoh K; Yamada Y; Sasaki T; Onogawa M; Yamanishi T; Kariya S; Nogami M; Nishioka A; Miyamura M
    Cancers (Basel); 2011 Sep; 3(3):3496-505. PubMed ID: 24212965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.